Benidipine: Difference between revisions

Benidipine
Clinical data
Routes of; administration	Oral
ATC code	C08CA15 (WHO) ;
Identifiers
	IUPAC name O5-methyl O3-[(3R)-1-(phenylmethyl)piperidin-3-yl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;
PubChem CID	60065;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C28H31N3O6
Molar mass	505.57 g·mol−1

VisualWikitext

Latest revision as of 20:29, 23 July 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Benidipine (INN), also known as Benidipinum or benidipine hydrochloride, is a dihydropyridine calcium channel blocker for the treatment of high blood pressure (hypertension).

Dosing

Benidipine is dosed as 2–4 mg once daily.^[1]

Availability

Benidipine is sold as Coniel by Kyowa Hakko Kogyo.

Benidipine is only licensed for use in Japan and selected Southeast Asian countries, where it is sold as 4 mg tablets.

References

↑ Hi-Eisai Pharmaceutical, Inc. "Coniel (benidipine) package insert (Philippines)". MIMS Philippines. CMPMedica. Retrieved 2008-03-31.

Template:Calcium channel blockers

[1] Hi-Eisai Pharmaceutical, Inc. "Coniel (benidipine) package insert (Philippines)". MIMS Philippines. CMPMedica. Retrieved 2008-03-31.

[1]

@@ Line 25: / Line 25: @@
 | routes_of_administration = Oral
 }}
+__NOTOC__
+{{CMG}}
-'''Benidipine''' ([[International Nonproprietary Name|INN]]), also known as Benidipinum or benidipine hydrochloride, is a dihydropyridine calcium channel blocker for the treatment of [[Hypertension|high blood pressure (hypertension)]].
+==Overview==
+'''Benidipine''' ([[International Nonproprietary Name|INN]]), also known as Benidipinum or benidipine hydrochloride, is a dihydropyridine calcium channel blocker for the treatment of [[Hypertension|high blood pressure (hypertension)]].
-==Dosing==
+== Dosing ==
-Benidipine is dosed as 2-4 mg once daily.<ref>{{cite web | url = http://www.mims-online.com/Page.aspx?menuid=mng&name=Coniel%20film-coated%20tab | title = Coniel (benidipine) package insert (Philippines) | author = Hi-Eisai Pharmaceutical, Inc. | accessdate = 2008-03-31 | publisher = CMPMedica | work = MIMS Philippines}}</ref>
+Benidipine is dosed as 2–4&nbsp;mg once daily.<ref>{{cite web | url = http://www.mims-online.com/Page.aspx?menuid=mng&name=Coniel%20film-coated%20tab | title = Coniel (benidipine) package insert (Philippines) | author = Hi-Eisai Pharmaceutical, Inc. | accessdate = 2008-03-31 | publisher = CMPMedica | work = MIMS Philippines}}</ref>
-==Availability==
+== Availability ==
-Benidipine is sold as '''Coniel®''' by Kyowa Hakko Kogyo.
+Benidipine is sold as '''Coniel''' by Kyowa Hakko Kogyo.
-Benidipine is only licensed for use in Japan and selected [[South East Asia|Southeast Asia]]n countries, where it is sold as 4 mg tablets.
+Benidipine is only licensed for use in Japan and selected [[South East Asia|Southeast Asian]] countries, where it is sold as 4&nbsp;mg tablets.
-==References==
+== References ==
-{{Reflist}}
+{{reflist|2}}
 {{Calcium channel blockers}}
-{{pharma-stub}}
 [[Category:Calcium channel blockers]]
-[[Category:Pyridines]]
+[[Category:Cardiovascular Drugs]]
+[[Category:Drug]]
-{{jb1}}
-{{WH}}
-{{WS}}

Clinical data

Routes of administration	Oral
ATC code	C08CA15 (WHO)
Identifiers
IUPAC name O5-methyl O3-[(3R)-1-(phenylmethyl)piperidin-3-yl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
PubChem CID	60065
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₈H₃₁N₃O₆
Molar mass	505.57 g·mol⁻¹